Email This Article

Headlines & Perspectives
Genentech's Herceptin Effective in Stomach Cancer: Study
By Samantha Shaddock
03/18/09 - 10:28 AM EDT
Roche announces that Genentech's breast cancer drug Herceptin prolonged the lives of some patients with stomach cancer.
Recipient's Email Address(es)
(Separate multiple addresses with a comma)
Your Email Address
Send a copy to myself
Your Message (optional)

Privacy Policy

The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.

Dow Jones S&P 500 NASDAQ 10-Year Note
10,465.61 1,105.88 2,188.80 35.40
Oil *
71.81
UP
59.78
UP
3.53
DOWN
2.06
UP
0.58
10 Yr
3.54%
SPDR Gold
109.40
+0.57%
+0.32%
-0.09%
+1.67%
Data delayed 20 minutes

Brokerage Partners